Nov 1, 2019 | biomarkers, oncology, precision medicine |
cancer is a collection of related diseases that can occur almost anywhere in the body and is characterized by abnormal cell process involving uncontrolled cell growth and proliferation that alters normal cell behaviour. there are over 100 types of cancers, and in all...
May 22, 2019 | car-t, innovation, precision medicine |
a few weeks ago, I attended the canadian agency for drugs and technologies in health [CADTH] symposium in edmonton, AB. the opening plenary discussion was on ‘the hope and hype’ in healthcare. your perspective on this, of course, depends on how you’re...
Mar 25, 2019 | car-t, innovation, precision medicine |
with recent health canada approvals of two new car-t cell treatments [tisagenlecleucel in september 2018 and [axicabtagene ciloleuce] in february 2019], canada is slowly starting to join the car-t club [at this time car-t has been approved in the USA and the UK]....
Mar 13, 2019 | innovation, precision medicine |
last week i had the opportunity to attend the international experience exchange for patient organizations [IEEPO] in rome, italy. the theme — “personalised healthcare- what’s in for patients” explored topics like digital health interventions, data...
Mar 5, 2019 | innovation, precision medicine |
personalised medicine is widely considered as the way of the future for medicine, especially in cancer, where we are moving away from the one size fits all, trial and error model towards a more tailored, personalized approach. and this has the potential to change the...
